Warren Fingrut

Warren Fingrut is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on allogeneic and autologous hematopoietic cell transplantation, particularly optimizing donor selection and post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis. He investigates melphalan pharmacokinetics in multiple myeloma conditioning regimens, social determinants of health in hematology, and equitable, inclusive care for patients with disabilities undergoing transplantation. His recent work includes personalized donor age and type modeling, Bayesian analysis of drug exposure-response relationships, and prospective studies collecting granular social determinants data for transplant patients.